EffPha meets you at BIO Asia- Taiwan Exhibition 2024
Exhibitor: EFFICIENT PHARMA MANAGEMENT CORP.
Date: 2024-07-05
Booth No.: M720
EffPha is a full-service CRO providing drug development services, including strategic and technical consulting, non-clinical study management, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has a team of Scientific Directors with more than 30 years of experience in global drug development, the Senior Manager who has designed numerous clinical protocols with extensive experience in regulatory affairs, the Clinical Director with over 25 years of experience in clinical management and monitoring, and the Manager of Biostatistics and Data Management who excels at statistical analysis plan (SAP) design and handling of clinical data analysis. They will be present at our booth to interact with visitors. We warmly welcome you to visit us at BIO Asia- Taiwan Exhibition 2024, and we are open to discussing any questions you have related to drug development and/or clinical trials.
Also, you can learn more details of EffPha’s services on our website at https://www.effpha.com/ as well as via our company video by clinking the link < EffPha Company Video >.
Come visit EffPha at our booth number M720 in the CRO zone on the 4th floor, at the Nangang Exhibition Center Hall 1 (4F, No.1, Jingmao 2nd Rd., Nangang District, Taipei City, Taiwan). Upon entering through the entrance of the M zone, please walk straight ahead.
More Exhibitor's Press Release
- Taiwan’s Regenerative Medicine Acts passed, MYCENAX CDMO Services Are Ready! MYCENAX BIOTECH INC. / 2024-07-08
- Registration Today! 2024 BIO Asia Taiwan. Golden Biotech Seminar Registration GOLDEN BIOTECHNOLOGY CORP. / 2024-07-06
- EffPha – An expert-based CRO for your drug development EFFICIENT PHARMA MANAGEMENT CORP. / 2024-07-05
- Featured Product: Saltonase, the Versatile Nuclease - Salt Tolerant and Easier Purification QIAGEN N.V. / 2024-07-05
- Vega Preclinical Ultrasound System J & H TECHNOLOGY CO., LTD. / 2024-07-05
- MYCENAX，YOUR BEST PARTNER FOR BIOLOGICS DEVELOPMENT MYCENAX BIOTECH INC. / 2024-07-04
- Bora Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility BORA PHARMACEUTICALS CO., LTD. / 2024-07-03
- Application and Market Development of Foods with Functional Claims in Japan GREENLINK BIOTECH INC. / 2024-07-03
- Featured Product: QIAGEN Beverly Single-Tube Enzymatic Fragmentation Library Preparation QIAGEN N.V. / 2024-07-02
- OEM by QIAGEN: Strategic Partnerships – A Partner that Extends Your Capabilities QIAGEN N.V. / 2024-07-02
- Comparison of Maglev Centrifugal Pump and Quaternary Diaphragm Pump Effects on mRNA encapsulated LNP LEVITRONIX GMBH TAIWAN BRANCH / 2024-07-01
- CRISPR cGMP gRNA Manufacturing MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- High-Throughput NGS Assistant - Feyond-F100 Fluorescence Microplate Reader MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- CLUBIO Life science solutions help universities upgrade equipments MEDCLUB SCIENTIFIC CO., LTD. / 2024-06-27
- EDA providing the most advanced and innovative optoelectronic medical equipment. EDA MEDICAL DEVICES TECHNOLOGY INC. / 2024-06-25
- TaiMed Biologics: Comprehensive CDMO Services from Bench to Market TAIMED BIOLOGICS INC. / 2024-06-25
- Marker X Decodes the Cancer Proteome Breaking the Limits of Early Cancer Screening Globally! MARKER EXPLORATION CORP. / 2024-06-21
- EffPha is the leading CRO for early phase oncology trials EFFICIENT PHARMA MANAGEMENT CORP. / 2024-06-20
- FUJIFILM Toyama Chemical and Synplogen Enter Strategic Business Alliance Agreement on CDMO Services FUJIFILM CORPORATION / 2024-06-18
- TriLink BioTechnologies® and FUJIFILM Toyama Chemical Sign Non-exclusive License FUJIFILM CORPORATION / 2024-06-18
